Jeremy Bender

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ryan Cohlhepp, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jeremy Bender

Form 4 holding Director

Mereo BioPharma Group plc

Security class
Share Options (Right to buy)
Shares / value
66,000
Estimated value
$55,550
Report date
26 Feb 2026
Price
$1.01
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
Form 4 holding Director

Mereo BioPharma Group plc

Security class
Deferred Restricted Stock Units
Shares / value
117,533
Estimated value
Report date
26 Feb 2026
Price
Ownership
Direct
Underlying class
American Depository Shares
Underlying amount
Form 4 holding Director

Fusion Pharmaceuticals Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
04 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jeremy Bender

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .